Advanced search
Publication Cover
mAbs Volume 11, 2019 - Issue 1
Submit an article Journal homepage
7,860
Views
64
CrossRef citations to date
0
Altmetric
Report

Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeutics

Robert G. BrinsonInstitute of Bioscience and Biotechnology Research, National Institute of Standards and Technology and the University of Maryland, Rockville, MD, USACorrespondence[email protected]
View further author information
,
John P. MarinoInstitute of Bioscience and Biotechnology Research, National Institute of Standards and Technology and the University of Maryland, Rockville, MD, USAView further author information
,
Frank DelaglioInstitute of Bioscience and Biotechnology Research, National Institute of Standards and Technology and the University of Maryland, Rockville, MD, USAView further author information
,
Luke W. ArbogastInstitute of Bioscience and Biotechnology Research, National Institute of Standards and Technology and the University of Maryland, Rockville, MD, USAORCID Iconhttps://orcid.org/0000-0001-6871-450XView further author information
ORCID Icon,
Ryan M. EvansApplied and Computational Mathematics Division, National Institute of Standards and Technology, Gaithersburg, MD, USAView further author information
,
Anthony KearsleyApplied and Computational Mathematics Division, National Institute of Standards and Technology, Gaithersburg, MD, USAView further author information
,
Geneviève GingrasCentre for Biologics Evaluation, Biologics and Genetic Therapies Directorate, Health Canada, Ottawa, ON, CanadaView further author information
,
Houman GhasrianiCentre for Biologics Evaluation, Biologics and Genetic Therapies Directorate, Health Canada, Ottawa, ON, CanadaORCID Iconhttps://orcid.org/0000-0002-9646-0006View further author information
ORCID Icon,
Yves AubinCentre for Biologics Evaluation, Biologics and Genetic Therapies Directorate, Health Canada, Ottawa, ON, CanadaORCID Iconhttps://orcid.org/0000-0002-8554-0297View further author information
ORCID Icon,
Gregory K. PierensThe Centre for Advanced Imaging, The University of Queensland, St Lucia, QLD, AustraliaView further author information
,
Xinying JiaThe Centre for Advanced Imaging, The University of Queensland, St Lucia, QLD, AustraliaORCID Iconhttps://orcid.org/0000-0002-2831-4605View further author information
ORCID Icon,
Mehdi MobliThe Centre for Advanced Imaging, The University of Queensland, St Lucia, QLD, AustraliaORCID Iconhttps://orcid.org/0000-0003-2420-4262View further author information
ORCID Icon,
Hamish G. GrantBio21 Molecular Science & Biotechnology Institute, The University of Melbourne, Victoria, AustraliaView further author information
,
David W. KeizerBio21 Molecular Science & Biotechnology Institute, The University of Melbourne, Victoria, AustraliaView further author information
,
Kristian SchweimerLehrstuhl Biopolymere, Universitaet Bayreuth, Bayreuth, GermanyView further author information
,
Jonas StåhleDepartment of Organic Chemistry, Arrhenius Laboratory, Stockholm University, Stockholm, SwedenORCID Iconhttps://orcid.org/0000-0001-5657-8635View further author information
ORCID Icon,
Göran WidmalmDepartment of Organic Chemistry, Arrhenius Laboratory, Stockholm University, Stockholm, SwedenView further author information
,
Edward R. ZartlerAnalytical R&D, Pfizer Essential Health, Lake Forest, IL, USAView further author information
,
Chad W. LawrencePacific Northwest National Laboratory, Earth and Biological Sciences Directorate, Richland, DC, USAView further author information
,
Patrick N. ReardonPacific Northwest National Laboratory, Earth and Biological Sciences Directorate, Richland, DC, USAORCID Iconhttps://orcid.org/0000-0002-6858-0086View further author information
ORCID Icon,
John R. CortPacific Northwest National Laboratory, Earth and Biological Sciences Directorate, Richland, DC, USAORCID Iconhttps://orcid.org/0000-0001-6342-6461View further author information
ORCID Icon,
Ping XuDepartment of Downstream Processing and Analytics, Human Health Therapeutics Research Centre, National Research Council of Canada, Montreal, Quebec, CanadaView further author information
,
Feng NiDepartment of Downstream Processing and Analytics, Human Health Therapeutics Research Centre, National Research Council of Canada, Montreal, Quebec, CanadaView further author information
,
Saeko YanakaInstitute for Molecular Science and Exploratory Research Center on Life and Living Systems, National Institutes of Natural Sciences, Myodaiji, Okazaki, JapanView further author information
,
Koichi KatoInstitute for Molecular Science and Exploratory Research Center on Life and Living Systems, National Institutes of Natural Sciences, Myodaiji, Okazaki, JapanView further author information
,
Stuart R. ParnhamDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USAORCID Iconhttps://orcid.org/0000-0002-8205-5827View further author information
ORCID Icon,
Desiree TsaoAnalytical Development, Momenta Pharmaceuticals, Cambridge, MA, USAView further author information
,
Andreas BlomgrenLaboratory Unit, Swedish Medical Products Agency, Laboratory, Uppsala, SwedenORCID Iconhttps://orcid.org/0000-0001-8171-4678View further author information
ORCID Icon,
Torgny RundlöfLaboratory Unit, Swedish Medical Products Agency, Laboratory, Uppsala, SwedenORCID Iconhttps://orcid.org/0000-0001-9004-7272View further author information
ORCID Icon,
Nils TrieloffNMR-supported Structural Biology, Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, GermanyORCID Iconhttps://orcid.org/0000-0002-3530-9273View further author information
ORCID Icon,
Peter SchmiederNMR-supported Structural Biology, Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, GermanyView further author information
,
Alfred RossRoche Pharmaceutical Research & Early Development, Pre-Clinical CMC, Roche Innovation Center Basel, Basel, SwitzerlandView further author information
,
Ken SkidmoreAnalytical Operations, Genentech, South San Francisco, CA, USAView further author information
,
Kang ChenCenter for Drug Evaluation and Research, Food and Drug Administration, Maryland, USAORCID Iconhttps://orcid.org/0000-0003-0276-2474View further author information
ORCID Icon,
David KeireCenter for Drug Evaluation and Research, Food and Drug Administration, Maryland, USAORCID Iconhttps://orcid.org/0000-0002-7767-7904View further author information
ORCID Icon,
Darón I. FreedbergCenter for Biologics Evaluation and Research, Food and Drug Administration, Maryland, USAORCID Iconhttps://orcid.org/0000-0003-1991-5174View further author information
ORCID Icon,
Thea Suter-StahelDepartment of Biology, Institute of Molecular Biology and Biophysics, ETH Zurich, Zurich, SwitzerlandView further author information
,
Gerhard WiderDepartment of Biology, Institute of Molecular Biology and Biophysics, ETH Zurich, Zurich, SwitzerlandView further author information
,
Gregor IlcNMR Centre, EN-FIST Centre of Excellence, Ljubljana, Slovenia;NMR Centre, National Institute of Chemistry, Ljubljana, SloveniaView further author information
,
Janez PlavecNMR Centre, EN-FIST Centre of Excellence, Ljubljana, Slovenia;NMR Centre, National Institute of Chemistry, Ljubljana, SloveniaORCID Iconhttps://orcid.org/0000-0003-1570-8602View further author information
ORCID Icon,
Scott A. BradleyEli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USAView further author information
,
Donna M. BaldisseriMRS – Application Science, Bruker BioSpin Corporation, Billerica, MA, USAView further author information
,
Mauricio Luis SforçaBrazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, BrazilView further author information
,
Ana Carolina de Mattos ZeriBrazilian Synchrotron Light Laboratory (LNLS), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, Brazil, CEPView further author information
,
Julie Yu WeiProtein Product Development, Biogen Inc., Cambridge, MA, USAView further author information
,
Christina M. SzaboBaxter Pharmaceuticals R&D, Baxter Healthcare, Round Lake, IL, USAORCID Iconhttps://orcid.org/0000-0003-0403-6337View further author information
ORCID Icon,
Carlos A. AmezcuaBaxter Pharmaceuticals R&D, Baxter Healthcare, Round Lake, IL, USAORCID Iconhttps://orcid.org/0000-0003-1644-8689View further author information
ORCID Icon,
John B. JordanGlobal Regulatory and R&D Policy, Amgen Inc., Thousand Oaks, CA, USAView further author information
&
Mats WikströmHigher Order Structure, Attribute Sciences, Amgen Inc., Thousand Oaks, CA, USAView further author information
 show all
Pages 94-105 | Received 12 Jul 2018, Accepted 31 Oct 2018, Published online: 22 Dec 2018

Related Research Data

NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy
Source: Oxford University Press (OUP)
Recommendations for the presentation of NMR structures of proteins and nucleic acids. IUPAC-IUBMB-IUPAB Inter-Union Task Group on the Standardization of Data Bases of Protein and Nucleic Acid Structures Determined by NMR Spectroscopy.
Source: Springer Science and Business Media LLC
Multivariate Analysis of Two-Dimensional 1H, 13C Methyl NMR Spectra of Monoclonal Antibody Therapeutics To Facilitate Assessment of Higher Order Structure.
Source: American Chemical Society (ACS)
Biosimilar structural comparability assessment by NMR: from small proteins to monoclonal antibodies.
Source: Springer Science and Business Media LLC
The Importance of Not Saturating H2o in Protein NMR : application to Sensitivity Enhancement and Noe Measurements
Source: American Chemical Society (ACS)
Using chemical shift perturbation to characterise ligand binding.
Source: Elsevier BV
Poisson-Gap Sampling and Forward Maximum Entropy Reconstruction for Enhancing the Resolution and Sensitivity of Protein NMR Data
Source: American Chemical Society (ACS)
State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization Volume 1. Monoclonal Antibody Therapeutics: Structure, Function, and Regulatory Space
Source: AMERICAN CHEMICAL SOCIETY
Gradient-Tailored Water Suppression for 1H-15N HSQC Experiments Optimized to Retain Full Sensitivity
Source: Elsevier BV
Mapping Monoclonal Antibody Structure by 2D 13C NMR at Natural Abundance
Source: American Chemical Society (ACS)
Assessment of the higher order structure of Humira®, Remicade®, Avastin®, Rituxan®, Herceptin®, and Enbrel® by 2D-NMR fingerprinting.
Source: Elsevier BV
State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb Case Study
Source: AMERICAN CHEMICAL SOCIETY
SOFAST-HMQC experiments for recording two-dimensional heteronuclear correlation spectra of proteins within a few seconds.
Source: Springer Science and Business Media LLC
What NMR can do in the biopharmaceutical industry
Source: Elsevier BV
Application of Natural Isotopic Abundance ¹H-¹³C- and ¹H-¹⁵N-Correlated Two-Dimensional NMR for Evaluation of the Structure of Protein Therapeutics.
Source: Elsevier
Technical Decision‐Making with Higher Order Structure Data: Starting a New Dialogue
Source: Elsevier BV
Trends and Drivers for the Development of Next-Generation Biotherapeutic Characterization Tools
Source: AMERICAN CHEMICAL SOCIETY
NMRPipe: a multidimensional spectral processing system based on UNIX pipes
Source: Springer Science and Business Media LLC
Precision and robustness of 2D-NMR for structure assessment of filgrastim biosimilars.
Source: Springer Science and Business Media LLC
Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy
Source: Elsevier BV

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.